Correlation Between Cingulate and Enlivex Therapeutics

Can any of the company-specific risk be diversified away by investing in both Cingulate and Enlivex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate and Enlivex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cingulate and Enlivex Therapeutics, you can compare the effects of market volatilities on Cingulate and Enlivex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate with a short position of Enlivex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate and Enlivex Therapeutics.

Diversification Opportunities for Cingulate and Enlivex Therapeutics

0.02

Correlation Coefficient

Cingulate  Enlivex Therapeutics

Significant diversification

The 3 months correlation between Cingulate and Enlivex is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate and Enlivex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enlivex Therapeutics and Cingulate is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate are associated (or correlated) with Enlivex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enlivex Therapeutics has no effect on the direction of Cingulate i.e., Cingulate and Enlivex Therapeutics go up and down completely randomly.

Pair Corralation between Cingulate and Enlivex Therapeutics

Given the investment horizon of 90 days Cingulate is expected to generate 1.21 times more return on investment than Enlivex Therapeutics. However, Cingulate is 1.21 times more volatile than Enlivex Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Enlivex Therapeutics is currently generating about -0.08 per unit of risk. If you would invest  492.00  in Cingulate on October 21, 2024 and sell it today you would lose (16.00) from holding Cingulate or give up 3.25% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Cingulate  vs.  Enlivex Therapeutics

Cingulate

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Cingulate are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Cingulate may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Enlivex Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Enlivex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Cingulate and Enlivex Therapeutics

The main advantage of trading using opposite Cingulate and Enlivex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate position performs unexpectedly, Enlivex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enlivex Therapeutics will offset losses from the drop in Enlivex Therapeutics' long position.

The idea behind Cingulate and Enlivex Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.